Koru Medical Systems, INC Form 4 insider transactions

Adam R Kalbermatten, President and CEO of KORU Medical Systems, Inc., received 284,091 shares of common stock on July 1, 2026.

Koru Medical Systems, Inc. reports that President and CEO Adam R. Kalbermatten was granted performance stock units under his employment agreement.

Koru Medical Systems Director Edward Whihhan reports acquisition of 3,571 shares of common stock.

Matin Shahriar, a Director at KORU Medical Systems, Inc., reported the acquisition of 3,571 shares of common stock on July 1, 2026.

Donna French, a Director at KORU Medical Systems, Inc., reported the acquisition of 3,571 shares of common stock on July 1, 2026.

KORU Medical Systems Director John R. Fletcher acquired 5,357 shares of common stock on July 1, 2026, at a price of $4.20 per share.

KORU Medical Systems, Inc. reports a transaction where Director Robert Cascella acquired 3,571 shares of common stock.

Koru Medical Systems, Inc. reports on director compensation and beneficial ownership changes involving Joseph M. Manko Jr. and affiliated entities.

Adam R. Kalbermatten, President-Chief Commercial Officer of KORU Medical Systems, Inc., acquired 12,500 shares of common stock through two transactions on June 11, 2026.

Eric Schiller, Chief Technology Officer of KORU Medical Systems, Inc., reported a transaction involving 5,000 shares of common stock.

KORU Medical Systems files an amendment to a Form 4, correcting a price entry for a transaction by CEO Linda M. Tharby.

KORU Medical Systems CEO Linda M. Tharby reported the acquisition of 1,191 shares of common stock on May 15, 2026.

KORU Medical Systems CEO Linda Tharby has reported transactions involving common stock, including the acquisition of shares upon vesting of restricted stock units and shares withheld for tax obligations.

KORU Medical Systems reports a Form 4 filing detailing the acquisition of common stock by Chief Operating Officer Christopher Pazdan.

KORU Medical Systems reports a stock purchase by its Chief Operating Officer, Christopher Pazdan.

Thomas Edward Adams, Chief Financial Officer of KORU Medical Systems, Inc., reported transactions involving common stock, including the acquisition of 8,193 shares upon vesting of restricted stock units and the withholding of 2,900 shares for tax obligations.

KORU Medical Systems' Chief Financial Officer, Thomas Edward Adams, has acquired a significant number of company shares through a Rule 10b5-1(c) plan.

Horton Capital Partners Fund, LP reports an amendment to its beneficial ownership of KORU Medical Systems, Inc. following a director compensation grant.

KORU Medical Systems Director Shahriar Matin acquired 3,472 shares of common stock at $4.32 per share.

KORU Medical Systems Director Donna French acquired 3,472 shares of common stock, increasing her beneficial ownership.

KORU Medical Systems Director Edward Wholihan acquired 3,472 shares of common stock at $4.32 per share, increasing his beneficial ownership to 47,741 shares.

KORU Medical Systems Director Robert Cascella plans to acquire 3,472 shares of common stock at $4.32 per share on April 1, 2026.

KORU Medical Systems Chairman R. John Fletcher acquired 5,208 shares of common stock at $4.32 per share, increasing his beneficial ownership.

Joseph M. Manko, Jr., a Director and 10% owner of KORU Medical Systems, Inc., received a grant of 3,472 common shares for his board service.

KORU Medical Systems CFO Thomas Edward Adams reported the vesting of restricted stock units, subsequent tax-related share disposals, and new equity awards including RSUs, PSUs, and stock options.

KORU Medical Systems CEO Linda M Tharby reported the vesting of restricted stock units and subsequent tax-related share disposition.

Joseph M. Manko, Jr. and Horton Capital entities restructured KORU Medical Systems shareholdings through internal distributions.

KORU Medical Systems' Chief Technology Officer, Eric Schiller, was granted 76,426 restricted stock units and options to purchase 232,297 shares of common stock as an employment inducement award.

KORU Medical Systems' Chief Financial Officer, Thomas Edward Adams, was granted 75,000 restricted stock units under the company's 2024 Omnibus Equity Incentive Plan.

A KORU Medical Systems director and 10% owner reported the acquisition of shares for director service and a gift transfer of shares.